2013-05-13 • Generics and Biosimilars Initiative Journal
2013-05-13 • Generics and Biosimilars Initiative Journal
The lack of clear regulatory guidance remains a key bottleneck for securing a second quality-assured source of liposomal amphotericin B (LAmB), the WHO-recommended drug for visceral leis...